Mutagenesis within human FcεRIα differentially affects human and murine IgE binding

Journal of Immunology

Volumn 168, Issue 4, 2002, Pages 1787-1795

  Mackay, Graham A ^a   Hulett, Mark D ^a   Cook, Justin P D ^a   Trist, Halina M ^a   Henry, Alistair J ^a   McDonnell, James M ^a   Beavil, Andrew J ^a   Beavil, Rebecca L ^a   Sutton, Brian J ^a   Hogarth, P Mark ^a   Gould, Hannah J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; RECEPTOR SUBUNIT; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PURIFICATION; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; ANIMAL; BASOPHIL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; COMPARATIVE STUDY; DEGRANULATION; GENETICS; HISTAMINE RELEASE; IMMUNOLOGY; KINETICS; METABOLISM; PICHIA; PROTEIN TERTIARY STRUCTURE; RAT; SPECIES DIFFERENCE; SURFACE PLASMON RESONANCE;

ANIMALS; BASOPHILS; CELL DEGRANULATION; CIRCULAR DICHROISM; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; KINETICS; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PICHIA; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, IGE; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; SURFACE PLASMON RESONANCE; TUMOR CELLS, CULTURED;

EID: 0037082326     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.4.1787     Document Type: Article

References (51)

1. The human IgE network
2. The cells of the allergic response: Mast cells, basophils, and eosinophils
3. Fc receptors
4. The high-affinity IgE receptor (FcεRI): From physiology topathology
5. Mast cells
6. The Fc receptor (FcR) γ subunit is essential for IgE-binding activity of cell-surface expressed chimeric receptor molecules constructed from human high-affinity IgE receptor (FcεRI) α and FcRγ subunits
7. A novel role for the Fc receptor γ subunit: Enhancement of FcRγ ligand affinity
8. Therapeutic potential of anti-IgE antibodies
9. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE aritibody
10. Regulation of IgE-mediated inflammation by soluble fragments of the high affinity IgE receptor
11. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria
12. Anti-FcεRIα autoantibodies in autoimmune-mediated disorders: Identification of a structure-function relationship
13. Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction
14. Expression of recombinant soluble FcεRI: Function and tissue distribution studies
15. Soluble form of the human high-affinity receptor for IgE inhibits recurrent allergic reaction in a novel mouse model of type 1 allergy
16. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor
17. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
18. Crystal structure of the human high-affinity IgE receptor
19. Identification of the immunoglobulin binding regions (IBR) of FcγRII and FcεRI
20. Chimeric Fc receptors identify immunoglobulin-binding regions in human FcγRII and FcεRI
21. Identification of sites on the human FcεRIα subunit which are involved in binding human and mt IgE
22. Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor α-subunit ectodomain: Domain localization of the IgE-binding site
23. Receptor phage: Display of functional domains of the human high affinity IgE receptor on the M13 phage surface
24. The immunoglobulin-like modules Cε3 and α2 are the minimal units necessary for human IgE-FcεRI interaction
25. Crystal structure of the human leukocyte Fc receptor, FcγRIIa
26. Crystal structure of the soluble form of the human FcγRIIb: A new member of the immunoglobulin superfamily at 1.7 Å resolution
27. Crystal structure of the extracellular domain of human FcγRIII
28. High affinity IgE-receptor α-subunit-derived peptides as antagonists of human IgE binding
29. Identification of contact residues in the IgE binding site of human FcεRIα
30. Fine structure analysis of the interaction of FcεRI with IgE
31. Structure-based design of peptides that inhibit IgE binding to its high-affinity receptor FcεRI
32. Domain one of the high affinity IgE receptor, FcεRI, regulates binding to IgE through its interface with domain two
33. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
34. Recent advances in the expression of foreign genes in Pichia pastoris
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
37. Interaction of the low-affinity receptor CD23/FcεRII lectin domain with the Fcε3-4 fragment of human immunoglobulin E
38. Participation of the N-terminal region of Cε3 in the binding of human IgE to its high-affinity receptor FcεRI
39. Studies of IgE-dependent histamine releasing factors: Heterogeneity of IgE
40. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling
41. A conformational rearrangement upon binding of IgE to its high affinity receptor
42. Characterization of truncated α chain products from human, rat, and mouse high affinity receptor for IgE
43. Glycosylation of human truncated FcεRI α chain is necessary for efficient folding in the endoplasmic reticulum
44. Complete structure and expression of the mouse mast cell receptor for IgE (FcεRI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells
45. High-level expression of the truncated α chain of human high-affinity receptor for IgE as a soluble form by baculovirus-infected insect cells: Biochemical characterization of the recombinant product
46. Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA
47. Peptide blocking of IgE/receptor interaction: Possibilities and pitfalls
48. Monoclonal antibodies and synthetic peptides define the active site of FcεRI and a potential receptor antagonist
49. A modeling study of the α-subunit of human high-affinity receptor for immunoglobulin-E
50. The interaction of IgE with rat basophilic leukemia cells. I. Evidence for specific binding of IgE
51. Binding properties of IgE receptors on normal mouse mast cells